1. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer
   Guoying Jin et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
2. Genetic alterations in anaplastic thyroid carcinoma and targeted therapies (Review)
   Zongjuan Li et al, 2019, Experimental and Therapeutic Medicine CrossRef
3. The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients
   M. N. Yurova, 2020, Advances in Gerontology CrossRef
4. Genetic alterations shaping tumor response to anti-EGFR therapies
   Javier Vaquero et al, 2022, Drug Resistance Updates CrossRef
5. Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
   Sae Ishihara et al, 2019, International Journal of Oncology CrossRef
6. Recent advances in the management of anaplastic thyroid cancer
   Simone De Leo et al, 2020, Thyroid Research CrossRef
7. Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer
   Wenbo Li et al, 2023, Technology in Cancer Research & Treatment CrossRef
8. Evaluating new treatments for anaplastic thyroid cancer
   Andrés Coca-Pelaz et al, 2022, Expert Review of Anticancer Therapy CrossRef
9. Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells
   Kento Kurata et al, 2016, International Journal of Oncology CrossRef
10. Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study
    Latha Durai et al, 2021, Molecular Biology Reports CrossRef